Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Globally, M&A activity dropped 42% in Q3. Against...
ChemPartner, a CRO based in Shanghai, has reportedly...
Last week, two China biopharmas made announcements about...
ShangPharma, the Shanghai-based CRO, formally announced...
Last week, Regenerx was awarded a patent in China for its...
WuXi PharmaTech, the Shanghai CRO that conforms to...
For a change, a China-based biopharma released a Q3...
ShanghaiBio Corporation, a maker of diagnostic tools that...
The dollar value of China’s pharmaceutical market...
China's economy made an indelible impression on the world...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
